News
Featured News
Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.
BIOVECTRA is Honoured With 2025 CDMO Leadership Award, BIOLOGICS — Industry Recognizes BIOVECTRA’s Excellence in Microbial Fermentation, Recombinant Protein Production, and Aseptic Fill-Finish Capabilities.
March 6, 2025
Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies
Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies […]
BIOVECTRA – Hiring Practices – The Employment Journey on PEI
BioVectra is a custom manufacturer of pharmaceutical ingredients for pharma companies. […]
BIOVECTRA Announces Acquisition of Former Sunovion (Sepracor) Facility
June 23, 2014 BIOVECTRA Announces Acquisition of Former Sunovion (Sepracor) Facility BIOVECTRA, a specialized cGMP manufacturer, and developer of pharmaceutical ingredients has announced today that […]
BIOVECTRA Spending $3.8 Million on Expansion
June 14, 2014 BIOVECTRA Spending $3.8 Million on Expansion An Island company that has been in business for more than 40 years is growing as […]
BIOVECTRA Starts Construction to Expand Charlottetown Facility
June 11, 2014 BIOVECTRA Starts Construction to Expand Charlottetown Facility BIOVECTRA, a specialized manufacturer and developer of pharmaceutical ingredients for the global marketplace, has commenced […]
Risk Management in Financing of Capital Expansions
BioVectra Inc. is an eastern Canadian contract manufacturing organization (CMO) with expertise in both synthetic chemistry and biomanufacturing techniques. […]
